Department of Otorhinolaryngology-Head and Neck Surgery, The Affiliated Lihuili Hospital, Ningbo University, Ningbo, 315040, Zhejiang, China.
Cancer Gene Ther. 2024 Jan;31(1):18-27. doi: 10.1038/s41417-023-00691-2. Epub 2023 Nov 15.
Single-cell sequencing (SCS) is a technology that separates thousands of cells from the organism and accurately analyzes the genetic material expressed in each cell using high-throughput sequencing technology. Unlike the traditional bulk sequencing approach, which can only provide the average value of a cell population and cannot obtain specific single-cell data, single-cell sequencing can identify the gene sequence and expression changes of a single cell, and reflects the differences between genetic material and protein between cells, and ultimately the role played by the tumor microenvironment. single-cell sequencing can further explore the pathogenesis of head and neck malignancies from the single-cell biological level and provides a theoretical basis for the clinical diagnosis and treatment of head and neck malignancies. This article will systematically introduce the latest progress and application of single-cell sequencing in malignant head and neck tumors.
单细胞测序(SCS)是一种从生物体中分离出数千个细胞,并使用高通量测序技术准确分析每个细胞中表达的遗传物质的技术。与传统的批量测序方法不同,后者只能提供细胞群体的平均值,无法获得特定的单细胞数据,单细胞测序可以识别单个细胞的基因序列和表达变化,并反映细胞间遗传物质和蛋白质的差异,最终反映肿瘤微环境的作用。单细胞测序可以从单细胞生物学水平进一步探讨头颈部恶性肿瘤的发病机制,为头颈部恶性肿瘤的临床诊断和治疗提供理论依据。本文将系统介绍单细胞测序在恶性头颈部肿瘤中的最新进展和应用。